167 related articles for article (PubMed ID: 21463424)
1. Utility of the pulsatility index of the uterine arteries and human chorionic gonadotropin in a series of cases of placenta accreta.
Dueñas-Garcia OF; Diaz-Sotomayor M; Rico-Olvera H
J Obstet Gynaecol Res; 2011 Aug; 37(8):1112-6. PubMed ID: 21463424
[TBL] [Abstract][Full Text] [Related]
2. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta.
Matsumura N; Inoue T; Fukuoka M; Sagawa N; Fujii S
J Obstet Gynaecol Res; 2000 Apr; 26(2):81-7. PubMed ID: 10870298
[TBL] [Abstract][Full Text] [Related]
3. Conservative management of placenta previa-accreta by prophylactic uterine arteries ligation and uterine tamponade.
Ferrazzani S; Guariglia L; Triunfo S; Caforio L; Caruso A
Fetal Diagn Ther; 2009; 25(4):400-3. PubMed ID: 19786787
[TBL] [Abstract][Full Text] [Related]
4. Conservative management of morbidly adherant placenta - a case report and review of literature.
Khan M; Sachdeva P; Arora R; Bhasin S
Placenta; 2013 Oct; 34(10):963-6. PubMed ID: 23937959
[TBL] [Abstract][Full Text] [Related]
5. The use of serial betaHCG to plan surgical evacuation of retained placenta in a case of placenta accreta.
Kulkarni A; Draycott T
J Matern Fetal Neonatal Med; 2005 Apr; 17(4):295-7. PubMed ID: 16147840
[TBL] [Abstract][Full Text] [Related]
6. Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete.
Zhou J; Li J; Yan P; Ye YH; Peng W; Wang S; Wang XT
Placenta; 2014 Sep; 35(9):691-5. PubMed ID: 25063251
[TBL] [Abstract][Full Text] [Related]
7. Partial placenta increta and methotrexate therapy: three case reports.
Pinho S; Sarzedas S; Pedroso S; Santos A; Rebordão M; Avillez T; Casal E; Hermida M
Clin Exp Obstet Gynecol; 2008; 35(3):221-4. PubMed ID: 18754299
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy and safety of uterine artery chemoembolization in abnormal placental implantation complicated with postpartum hemorrhage].
Chen YT; Xu LF; Sun HL; Li HQ; Hu RM; Tan QY
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):273-7. PubMed ID: 20646539
[TBL] [Abstract][Full Text] [Related]
9. Conservative management of placenta praevia with a high risk of placenta accreta.
Dunstone SJ; Leibowitz CB
Aust N Z J Obstet Gynaecol; 1998 Nov; 38(4):429-33. PubMed ID: 9890226
[TBL] [Abstract][Full Text] [Related]
10. Conservative endovascular management of retained placenta accreta with marked vascularity after abortion or delivery.
Takeda A; Koike W
Arch Gynecol Obstet; 2017 Dec; 296(6):1189-1198. PubMed ID: 28980065
[TBL] [Abstract][Full Text] [Related]
11. Conservative management of placenta increta: case report and literature review.
Yarandi F; Eftekhar Z; Shojaei H; Rahimi-Sharbaf F; Baradaran F
Acta Med Iran; 2011; 49(6):396-8. PubMed ID: 21874645
[TBL] [Abstract][Full Text] [Related]
12. Placental blood flow disappears coincident with a fall in human chorionic gonadotropin to undetectable levels in conservative management of placenta accreta.
Imai S; Kondoh E; Kawasaki K; Mogami H; Ueda A; Umeoka S; Konishi I
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():199-201. PubMed ID: 24916034
[No Abstract] [Full Text] [Related]
13. Successful conservative management of placenta previa totalis and extensive percreta.
Yee YH; Kung FT; Yu PC; Hsu TY; Cheng YF
Taiwan J Obstet Gynecol; 2008 Dec; 47(4):431-4. PubMed ID: 19126510
[No Abstract] [Full Text] [Related]
14. Successful conservative management of placenta previa accreta during cesarean section.
Lam H; Pun TC; Lam PW
Int J Gynaecol Obstet; 2004 Jul; 86(1):31-2. PubMed ID: 15207668
[No Abstract] [Full Text] [Related]
15. Successful conservative treatment of placenta accreta with traditional Chinese medicine: A case report.
Huang H; Wang J; Li K; Ma H
Medicine (Baltimore); 2021 Feb; 100(7):e24820. PubMed ID: 33607847
[TBL] [Abstract][Full Text] [Related]
16. Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin.
Palacio M; Jauniaux E; Kingdom J; Dell E; Sheldrake A; Rodeck CH
Ultrasound Obstet Gynecol; 1999 Jan; 13(1):58-62. PubMed ID: 10201088
[TBL] [Abstract][Full Text] [Related]
17. Second-trimester maternal serum markers and placenta accreta.
Dreux S; Salomon LJ; Muller F; Goffinet F; Oury JF; ; Sentilhes L
Prenat Diagn; 2012 Oct; 32(10):1010-2. PubMed ID: 22729439
[No Abstract] [Full Text] [Related]
18. Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta.
Büke B; Akkaya H; Demir S; Sağol S; Şimşek D; Başol G; Barutçuoğlu B
J Matern Fetal Neonatal Med; 2018 Jan; 31(1):59-62. PubMed ID: 28027672
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of Placenta Accreta Spectrum Disorders: A Review of Current Findings.
Jauniaux E; Burton GJ
Clin Obstet Gynecol; 2018 Dec; 61(4):743-754. PubMed ID: 30299280
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 47 cases of placenta accreta in the second and third trimesters].
Zhang C; Liu XY; Fan GS; Yang JQ; Liu JT; Bian XM
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):506-9. PubMed ID: 19080513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
